Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.24%
#2 aelf aelf +23.74%
#3 Decred Decred +12.08%
#4 Bitway Bitway +10.57%
#5 AtomOne AtomOne +10.54%
#6 TRIA TRIA +9.39%
#7 Pons Pons +8.39%
#8 Wibx Wibx +8.12%
#9 Status Status +7.87%
#10 Starpower Starpower +7.61%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Perseus Proteomics Inc. Perseus Proteomics Inc.

Perseus Proteomics Inc.

4882
Rang in Aktien #30348
Based in Tokyo, Japan, Perseus Proteomics Inc. operates as a biotechnology... Based in Tokyo, Japan, Perseus Proteomics Inc. operates as a biotechnology venture specializing in the development of antibody-based therapeutics for various ailments, including cancer. Its core operations encompass pioneering antibody discovery, alongside providing extensive research support services. These services include hybridoma antibody sequencing, the production of antibody proteins, and undertaking contract antibody research projects. Furthermore, Perseus Proteomics supplies its own antibody products to the market. The company boasts a robust development pipeline featuring several promising candidates: PPMX-T001, an antibody targeting hepatocarcinoma; PPMX-T002, an oncology therapeutic; PPMX-T003, designed for the treatment of adult T-cell leukemia/lymphoma; and PPMX-T004, an innovative antibody-drug conjugate. Established in 2001, the firm maintains its headquarters in the Japanese capital.
Aktienkurs
$0.93298493
Marktkapitalisierung
$17.19M
Veränderung (1 Tag)
-1.38%
Veränderung (1 Jahr)
-62.47%
Land
JP
Handel Perseus Proteomics Inc. (4882)

Kategorie

Healthcare
Kursverlauf für Perseus Proteomics Inc. (4882)
Höchster Schlusskurs: $0.94 am 2026-08-01

Niedrigster Schlusskurs: $7.34 am 2021-06-01
Kursverlauf der Aktie von Perseus Proteomics Inc. von 2021 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -5.78%
2025 -60.94%
2024 -2.22%
2023 82.81%
2022 -26.01%
2021 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $1.23K 74.37%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $271.04 52.44%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $258.13 25.19%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $477.05 41.32%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $135.49 59.53%
US